FDA approves ReShape intragastric balloon device
August 21, 2015|GI and Hepatology News
Author and Disclosure Information
“It is gratifying to see that the FDA continues to facilitate technologies to address significant public health concerns,” said chair of the center, Dr. Michael L. Kochman, FACP, AGAF. “The AGA Center for GI Innovation and Technology’s obesity-focused meeting, held in conjunction with the FDA, and the annual AGA Tech Summits have helped inform the discussion surrounding the new and novel devices in the obesity and metabolism space.”
